Literature DB >> 13662631

Chemotherapy of pulmonary tuberculosis.

J CROFTON.   

Abstract

Entities:  

Keywords:  TUBERCULOSIS, PULMONARY/therapy

Mesh：

Year:  1959        PMID： 13662631      PMCID： PMC1993570          DOI： 10.1136/bmj.1.5138.1610

Source DB:  PubMed          Journal:  Br Med J        ISSN： 0007-1447


× No keyword cloud information.
  5 in total

1.  The prevalence of drug-resistant tubercle bacilli in untreated patients with pulmonary tuberculosis; a national survey, 1955-56.

Authors:  W FOX; A WIENER; D A MITCHISON; J B SELKON; I SUTHERLAND
Journal:  Tubercle       Date:  1957-04

2.  Sputkm conversion and the metabolism of isoniazid.

Authors:  J CROFTON
Journal:  Am Rev Tuberc       Date:  1958-05

3.  Hospital treatment of pulmonary tuberculosis; a follow-up study of patients admitted to Edinburgh hospitals in 1953.

Authors:  J D ROSS; N W HORNE; I W GRANT; J W CROFTON
Journal:  Br Med J       Date:  1958-02-01

4.  The influence of chemotherapy on the bacterial content of tuberculous pulmonary lesions.

Authors:  A R MACGREGOR; S M STEWART; F W TURNBULL
Journal:  Tubercle       Date:  1956-12

5.  Infectivity of pulmonary tuberculosis in relation to sputum status.

Authors:  J B SHAW; N WYNN-WILLIAMS
Journal:  Am Rev Tuberc       Date:  1954-05
  5 in total
  14 in total

1.  An assessment of antibacterial treatment used alone or in association with surgical operation in the treatment of pulmonary tuberculosis.

Authors:  J R EDGE; W H HELM; M R GEAKE; R L WARD
Journal:  Thorax       Date:  1961-09       Impact factor: 9.139

2.  Tuberculosis undefeated.

Authors:  J CROFTON
Journal:  Br Med J       Date:  1960-09-03

Review 3.  [Results of chemotherapy in tuberculosis].

Authors:  E Jancik
Journal:  Pneumonologie       Date:  1971

4.  [The clinical significance of the quantity of tubercle bacilli in the sputum during tuberculostatic treatment. II. The effect of 2 and 3-drug combinations on the tempo of decrease of the quantity of bacteria].

Authors:  I Seri
Journal:  Beitr Klin Erforsch Tuberk Lungenkr       Date:  1965-12-30

5.  [Difficulties in ethambutol dosage].

Authors:  I Schütz
Journal:  Pneumonologie       Date:  1971

6.  [Reasons for failures of chemotherapy in tuberculosis].

Authors:  H Sighart
Journal:  Beitr Klin Erforsch Tuberk Lungenkr       Date:  1968

Review 7.  The chemotherapy of tuberculosis: past, present and future.

Authors:  D Mitchison; G Davies
Journal:  Int J Tuberc Lung Dis       Date:  2012-06       Impact factor: 2.373

8.  N-acetyltransferase genotypes and the pharmacokinetics and tolerability of para-aminosalicylic acid in patients with drug-resistant pulmonary tuberculosis.

Authors:  Sherwin K B Sy; Lizanne de Kock; Andreas H Diacon; Cedric J Werely; Huiming Xia; Bernd Rosenkranz; Lize van der Merwe; Peter R Donald
Journal:  Antimicrob Agents Chemother       Date:  2015-05-11       Impact factor: 5.191

9.  Dose regimen of para-aminosalicylic acid gastro-resistant formulation (PAS-GR) in multidrug-resistant tuberculosis.

Authors:  Yves Kibleur; Hervé Brochart; Hendrik S Schaaf; Andre H Diacon; Peter R Donald
Journal:  Clin Drug Investig       Date:  2014-04       Impact factor: 2.859

Review 10.  Global tuberculosis control: lessons learnt and future prospects.

Authors:  Christian Lienhardt; Philippe Glaziou; Mukund Uplekar; Knut Lönnroth; Haileyesus Getahun; Mario Raviglione
Journal:  Nat Rev Microbiol       Date:  2012-05-14       Impact factor: 60.633
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.